AMANDA FRIESZ: Open Payments
NPI 1255047643 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$281 in 14 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $24 · 2025 $281
Food & beverage: $281
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $94 |
| Ardelyx, Inc. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 3 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Boston Scientific Corporation | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
Products named: Veozah, IBSRELA, REXULTI, INGEVITY+, CAPLYTA, VOQUEZNA, AIRSUPRA.
Industry payments across MO — which companies pay providers there.
